The University of North Texas Health Science Center built a flourishing business using hundreds of unclaimed corpses. It ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

California-based medical device company Axonics has won a patent infringement trial against Medtronic, according to a Sept. 19 report from Global Data. Medtronic alleged that the company copied three ...

The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s ...

GlobalData also noted that this is not the first recall for Medtronic’s laryngoscopes. In September 2023, the company issued a recall due to malfunctioning stolen devices that were distributed ...

Axonics, Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as the jury rules in its favor, awarding ...